Natalie Stone
Psychiatric/Mental Health · Bowling Green, KYNPI 1588376396
Payments from drug & device makers
Across 251 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$882
- Vanda Pharmaceuticals Inc.$512
- Axsome Therapeutics, Inc.$408
- Teva Pharmaceuticals USA, Inc.$368
- Alkermes, Inc.$347
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,74997%
- Education$1243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,872 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 29 | $167,268 |
| VraylarCariprazine Hcl | 41 | $58,722 |
| QuviviqDaridorexant Hcl | 16 | $8,314 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,177 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 68 | $2,692 |
| Buspirone Hcl | 40 | $441 |
| Sertraline Hcl | 21 | $418 |
| Lamotrigine | 41 | $410 |
| Quetiapine Fumarate | 23 | $362 |
| Gabapentin | 39 | $355 |
| Mirtazapine | 23 | $337 |
| Divalproex Sodium | 13 | $333 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $314 |
| Duloxetine Hcl | 11 | $301 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $368 | $167,26829 claims |
| AbbVieVraylar | $882 | $58,72241 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $30 | $8,31416 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $33 | $6,17713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Bowling Green
- Joy CorneliusBowling Green$24K
- Alicia KaramBowling Green$14K
- Phillip WalkerBowling Green$14K
- Brittany JacksonBowling Green$10K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.